Canada Unveils "Living" Cancer Test That Updates Over Time
A Canadian team has created GenTraceDx, the world's first cancer diagnostic that continuously updates as new treatments emerge, ensuring patients never miss a potential therapy. The $6 million platform launches a 500-patient pilot across Canada this fall.